EMILY HIGHTOWER: Open Payments
NPI 1336870781 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,102 in 106 payments from 34 companies in 2025. Trend: 2023 $2,166 · 2024 $1,984 · 2025 $2,102
Food & beverage: $2,102
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $233 |
| Janssen Biotech, Inc. | 11 | $216 |
| Daiichi Sankyo Inc. | 8 | $142 |
| Caris MPI, Inc. | 6 | $136 |
| Novartis Pharmaceuticals Corporation | 7 | $130 |
| PFIZER INC. | 5 | $123 |
| TerSera Therapeutics LLC | 5 | $114 |
| ARRAY BIOPHARMA INC | 5 | $84 |
| Regeneron Healthcare Solutions, Inc. | 4 | $80 |
| Merck Sharp & Dohme LLC | 4 | $79 |
Products named: MI CANCER SEEK, RYBREVANT, Enhertu, KEYTRUDA, TAGRISSO, CALQUENCE, IMFINZI, Xermelo.
Industry payments across AL — which companies pay providers there.
